1. Home
  2. TW vs ROIV Comparison

TW vs ROIV Comparison

Compare TW & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tradeweb Markets Inc.

TW

Tradeweb Markets Inc.

HOLD

Current Price

$102.24

Market Cap

22.9B

Sector

Finance

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$34.85

Market Cap

23.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TW
ROIV
Founded
1996
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
23.2B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
TW
ROIV
Price
$102.24
$34.85
Analyst Decision
Buy
Strong Buy
Analyst Count
12
9
Target Price
$135.25
$28.94
AVG Volume (30 Days)
1.4M
4.6M
Earning Date
04-29-2026
05-28-2026
Dividend Yield
0.47%
N/A
EPS Growth
62.23
N/A
EPS
0.96
N/A
Revenue
$892,659,000.00
$8,260,000.00
Revenue This Year
$18.07
N/A
Revenue Next Year
$10.66
$744.61
P/E Ratio
$103.99
N/A
Revenue Growth
15.10
N/A
52 Week Low
$91.42
$10.90
52 Week High
$147.49
$37.00

Technical Indicators

Market Signals
Indicator
TW
ROIV
Relative Strength Index (RSI) 55.21 55.66
Support Level $96.84 $33.56
Resistance Level $103.45 $37.00
Average True Range (ATR) 2.75 1.08
MACD 0.39 -0.24
Stochastic Oscillator 93.85 34.04

Price Performance

Historical Comparison
TW
ROIV

About TW Tradeweb Markets Inc.

Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in US and European government debt, mortgage-backed securities, interest-rate swaps, and US and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: